Tociluzimab administation and monitoring in Covid-19

N. Keidan (Newcastle, United Kingdom), A. Aujayeb (Newcastle, United Kingdom), A. Aujayeb (Newcastle, United Kingdom)

Source: International Congress 2022 – COVID infections prognosis: risk factors and treatment
Session: COVID infections prognosis: risk factors and treatment
Session type: Thematic Poster
Number: 3368

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Keidan (Newcastle, United Kingdom), A. Aujayeb (Newcastle, United Kingdom), A. Aujayeb (Newcastle, United Kingdom). Tociluzimab administation and monitoring in Covid-19. 3368

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.